| Group 1a (n = 19) | Group 1b (n = 21) | Group 2 (n = 8) | Group 3 (n = 13) | Group 4 (n = 10) | Group 5 (n = 8) | Group 6 (n = 13) | |
---|---|---|---|---|---|---|---|---|
Packed Cell Volume (%) | 13.6 ± 4.8 | 17.9 ± 4.3 | 25.0 ± 14.7 | 46.8 ± 9.9 | 44.1 ± 11.8 | 30.3 ± 15.1 | 46.9 ± 3.6 | |
(7.6-23) | (7.0-25.5) | (11.0-55.2) | (18.2-57.7) | (20.5-59.4) | (14.9-61.4) | (41.7-53.2) | ||
Mean Corpuscular Volume (fl) | 76.7 ± 5.1 | 77.7 ± 9.3 | 57.1 ± 3.3 | 68.9 ± 8.1 | 70.4 ± 4.5 | 66.5 ± 5.4 | 68.7 ± 2.4 | |
(70.7-88.4) | (67.1-96.3) | (50.4-60.0) | (62.7-77.2) | (62.9-77.3) | (60.0-76.7) | (63.0-71.2) | ||
Cholesterol concentration (mmol/l) | 6.73 ± 1.37 | 4.68 ± 3.18 | 3.58 ± 1.83 | 16.6 ± 11.0 | 4.95 ± 1.44 | 6.33 ± 1.48 | 6.81 ± 1.45 | |
(5.3-8.53)* | (0.83-12.7)** | (2.48-8.35) | (6.26-48.38) | (2.77-7.11) | (4.0-9.0) | (4.42-9.15) | ||
Triglyceride Concentration (mmol/l) | 0.87 ± 0.30 | 0.76 ± 0.28 | 0.71 ± 0.44 | 11.73 ± 9.36 | 0.75 ± 0.31 | 0.90 ± 0.34 | 0.89 ± 0.56 | |
(0.57-1.25)* | (0.41-1.19)** | (0.24-1.72) | (0.86-29.26) | (0.44-1.34) | (0.52-1.56) | (0.31-1.99) | ||
Number of spherocytes per high power field | <1 | 3 | 13 | 7 | 11 | 10 | 7 | 13 |
1-3 | 2 | 4 | 1 | 2 | 0 | 0 | 0 | |
3-5 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | |
≥5 | 12 | 1 | 0 | 0 | 0 | 1 | 0 | |
In-saline auto-agglutination | Positive | 16 | 0 | 0 | 0 | 0 | 0 | 0 |
Negative | 3 | 21 | 8 | 13 | 10 | 8 | 13 | |
Coombs’ test | Positive | 13 | 1 | 0 | 0 | 0 | 2 | 0 |
Negative | 4*** | 20 | 8 | 13 | 10 | 6 | 13 |